Analyst consensus rating
Opko Health Analyst Rating: Buy
OPK is rated Buy by 4 analysts with a $4.38 target. As of 2026-08-29.
Direct answer
Opko Health's consensus rating is Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.38.
Forecast evidence checked August 29, 2026.
Get free Opko Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.48
- Average price target
- $4.38
- High price target
- $8.50
- Low price target
- $3.00
- Low target gap
- +102.7%
- Target upside
- +195.6%
- High target gap
- +474.3%
- Target range width
- 371.6%
- Consensus rating
- Buy
- Analysts
- 4
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Opko Health?
Opko Health has a verified Buy consensus. The same dataset has an average price target of $4.38.
How far are Opko Health's low and high targets from the recorded price?
The low target implies +102.7%, while the high target implies +474.3%.
How many analysts are included in Opko Health's consensus?
The verified consensus includes 4 analysts.
How is Opko Health's target upside or downside calculated?
The average target of $4.38 is divided by the recorded price of $1.48, then one is subtracted to produce +195.6%. This does not guarantee a future return.
When was Opko Health's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.